Cardiac MRI Based Left Ventricular Global Function Index: Association with Disease Severity in Patients with ICD for Secondary Prevention
Authors:
- Andreas Leonhard SchoberASAndreas Leonhard Schober
- Carsten JungbauerCJCarsten Jungbauer
- Florian PoschenriederFPFlorian Poschenrieder
- Alexander Daniel SchoberASAlexander Daniel Schober
- Ute HubauerUHUte Hubauer
- Andreas KeyserAKAndreas Keyser
- Sabine Fredersdorf-HahnSFSabine Fredersdorf-Hahn
- Kurt DeblKDKurt Debl
- Lars S. MaierLMLars S. Maier
- Samuel SossallaSSSamuel Sossalla
- Stefan BuchnerSBStefan Buchner
- Ekrem ÜçerEÜEkrem Üçer
Open Access
- 27 October 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (21) , 4980
Abstract
Left ventricular (LV) ejection fraction (LVEF) is the most widely used prognostic marker in cardiovascular diseases. LV global function index (LVGFI) is a novel marker which incorporates the total LV structure in the assessment of LV cardiac performance. We evaluated the prognostic significance of LVGFI, measured by cardiovascular magnetic resonance (CMR), in predicting mortality and ICD therapies in a real-world (ICD) population with secondary ICD prevention indication, to detect a high-risk group among these patients. In total, 105 patients with cardiac MRI prior to the ICD implantation were included (mean age 56 ± 16 years old; 76% male). Using the MRI data for each patient LVGFI was determined and a cut-off for the LVGFI value was calculated. Patients were followed up every four to six months in our or clinics in proximity. Data on the occurrence of heart failure symptoms and or mortality, as well as device therapies and other vital parameters, were collected. Follow up duration was 37 months in median. The mean LVGFI was 24.5%, the cut off value for LVGFI 13.5%. According to the LVGFI Index patient were divided into 2 groups, 86 patients in the group with the higher LVGFI und 19 patients in the lower group. The LVGFI correlates significantly with the LVEF (r = 0.642, p < 0.001). In Kaplan–Meier analysis, a lower LVGFI ( I, the initial device or a medication (each p = n.s.). Further, in Kaplan–Meier analysis no association was evident between the LVGFI and adequate ICD therapy (p = n.s.). In secondary prevention ICD patients reduced LVGFI was shown as an independent predictor for mortality and rehospitalization, but not for ICD therapies. We were able to identify a high-risk collective among these patients, but further investigation is needed to evaluate LVGFI compared to ejection fraction, especially in patients with an elevated risk for adverse cardiac events.Keywords
This publication has 13 references indexed in Scilit:
- Reference values of cardiac volumes, dimensions, and new functional parameters by MR: A multicenter, multivendor studyJournal of Magnetic Resonance Imaging, 2016
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Heart Journal, 2016
- Prognostic value of left ventricular global function index in patients after ST-segment elevation myocardial infarctionEuropean Heart Journal - Cardiovascular Imaging, 2015
- Left ventricular global function index assessed by cardiovascular magnetic resonance for the prediction of cardiovascular events in ST-elevation myocardial infarctionJournal of Cardiovascular Magnetic Resonance, 2015
- Left Ventricular Global Function Index by Magnetic Resonance Imaging—A Novel Marker for Assessment of Cardiac Performance for the Prediction of Cardiovascular EventsHypertension, 2013
- The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failureJACC, 2003
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) StudyAmerican Heart Journal, 2001
- Randomized Comparison of Antiarrhythmic Drug Therapy With Implantable Defibrillators in Patients Resuscitated From Cardiac ArrestCirculation, 2000
- Canadian Implantable Defibrillator Study (CIDS)Circulation, 2000